Subscribe to RSS
Quality of Life in Women with Polycystic Ovary Syndrome after a Program of Resistance Exercise TrainingQualidade de vida em mulheres com síndrome de ovários policísticos após um programa de treinamento de exercício resistido
01 February 2016
23 May 2016
29 July 2016 (online)
Purpose Aerobic exercises may improve quality of life (QoL) in women with polycystic ovary syndrome (PCOS). However, there is no data on the effect of resistance exercise training (RET) programs on the QoL of women with PCOS. Thus, this study aimed to assess the effect of a 16-week RET program on QoL in PCOS women.
Methods This 16-week case-control study enrolled 43 women with PCOS (PCOS group, PCOSG) and 51 healthy pre-menopausal controls aged 18 to 37 years (control group, CG). All women underwent a supervised RET program for 16 weeks, and were evaluated in two different occasions: week-0 (baseline), and week-16 (after RET). Quality of life was assessed using the 36-Item Short Form Health Survey (SF-36).
Results Testosterone reduced significantly in both groups after RET (p < 0.01). The PCOSG had improvements in functional capacity at week-16 relative to week-0 (p = 0.02). The CG had significant improvements in vitality, social aspects, and mental health at week-16 relative to week-0 (p ≤ 0.01). There was a weak correlation between social aspects of the SF-36 domain and testosterone levels in PCOS women.
Conclusion A 16-week RET program modestly improved QoL in women with PCOS.
Objetivos Exercícios aeróbicos podem melhorar a qualidade de vida (QV) de mulheres com síndrome dos ovários policísticos (SOP). No entanto, não há dados sobre o efeito de um programa de treinamento de exercício resistido (TER) sobre a QV destas mulheres. Assim, este estudo teve como objetivo avaliar o efeito de um programa de TER de 16 semanas na QV em mulheres com SOP.
Métodos Estudo caso-controle com 16 semanas de duração, para o qual foram incluídas 43 mulheres com SOP (grupo com SOP, GSOP) e 51 controles saudáveis com idade entre 18 a 37 anos (grupo de controle, GC). Todas as mulheres foram submetidas ao protocolo TER supervisionado por 16 semanas, e foram avaliadas em dois momentos: na semana 0 (linha de base), e na semana 16 (após TER). A qualidade de vida foi avaliada pelo 36-Item Short Form Health Survey (SF-36).
Resultados Houve redução significativa da testosterona em ambos os grupos após o TER (p < 0,01). O GSOP obteve significativa melhora na capacidade funcional na semana 16 em relação à semana 0 (p = 0,02). O GC apresentou significativa melhora no escore do domínio vitalidade, aspectos sociais e saúde mental na semana 16 em relação à semana 0 (p ≤ 0,01). Houve uma fraca correlação entre os aspectos sociais de domínio SF-36 e o nível de testosterona em mulheres com SOP.
Conclusão a aplicação de um programa de treinamento físico resistido durante 16 semanas resultou em melhora modesta da QV de mulheres com SOP.
- 1 Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 2013; 6: 1-13
- 2 Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 2012; 33 (6) 981-1030
- 3 O'Reilly MW, Taylor AE, Crabtree NJ , et al. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. J Clin Endocrinol Metab 2014; 99 (3) 1027-1036
- 4 Benetti-Pinto CL, Ferreira SR, Antunes Jr A, Yela DA. The influence of body weight on sexual function and quality of life in women with polycystic ovary syndrome. Arch Gynecol Obstet 2015; 291 (2) 451-455
- 5 Drosdzol A, Skrzypulec V, Mazur B, Pawlińska-Chmara R. Quality of life and marital sexual satisfaction in women with polycystic ovary syndrome. Folia Histochem Cytobiol 2007; 45 (Suppl. 01) S93-S97
- 6 Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41
- 7 Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2011; (2) CD007506
- 8 Wing RR. Physical activity in the treatment of the adulthood overweight and obesity: current evidence and research issues. Med Sci Sports Exerc 1999; 31 (11, Suppl) S547-S552
- 9 Volek JS, Vanheest JL, Forsythe CE. Diet and exercise for weight loss: a review of current issues. Sports Med 2005; 35 (1) 1-9
- 10 Palomo T, Beninger RJ, Kostrzewa RM, Archer T. Affective status in relation to impulsive, motor and motivational symptoms: personality, development and physical exercise. Neurotox Res 2008; 14 (2–3) 151-168
- 11 Banting LK, Gibson-Helm M, Polman R, Teede HJ, Stepto NK. Physical activity and mental health in women with polycystic ovary syndrome. BMC Womens Health 2014; 14 (1) 51
- 12 Conte F, Banting L, Teede HJ, Stepto NK. Mental health and physical activity in women with polycystic ovary syndrome: a brief review. Sports Med 2015; 45 (4) 497-504
- 13 Thomson RL, Buckley JD, Lim SS , et al. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome. Fertil Steril 2010; 94 (5) 1812-1816
- 14 Kraemer WJ, Ratamess NA. Fundamentals of resistance training: progression and exercise prescription. Med Sci Sports Exerc 2004; 36 (4) 674-688
- 15 Joham AE, Teede HJ, Hutchison SK , et al. Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training. Obesity (Silver Spring) 2012; 20 (12) 2390-2396
- 16 Harrison CL, Stepto NK, Hutchison SK, Teede HJ. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome. Clin Endocrinol (Oxf) 2012; 76 (3) 351-357
- 17 Hutchison SK, Stepto NK, Harrison CL, Moran LJ, Strauss BJ, Teede HJ. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. J Clin Endocrinol Metab 2011; 96 (1) E48-E56
- 18 Giallauria F, Palomba S, Vigorito C , et al. Androgens in polycystic ovary syndrome: the role of exercise and diet. Semin Reprod Med 2009; 27 (4) 306-315
- 19 Goss AM, Chandler-Laney PC, Ovalle F , et al. Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS. Metabolism 2014; 63 (10) 1257-1264
- 20 Kogure GS, Piccki FK, Vieira CS, Martins WdeP, dos Reis RM. [Analysis of muscle strength and body composition of women with polycystic ovary syndrome]. Rev Bras Ginecol Obstet 2012; 34 (7) 316-322 Portuguese
- 21 Thomas S, Reading J, Shephard RJ. Revision of the Physical Activity Readiness Questionnaire (PAR-Q). Can J Sport Sci 1992; 17 (4) 338-345
- 22 Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30 (6) 473-483
- 23 McHorney CA, Ware Jr JE, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32 (1) 40-66
- 24 Matuszak ME, Fry AC, Weiss LW, Ireland TR, McKnight MM. Effect of rest interval length on repeated 1 repetition maximum back squats. J Strength Cond Res 2003; 17 (4) 634-637
- 25 Rhea MR, Phillips WT, Burkett LN , et al. A comparison of linear and daily undulating periodized programs with equated volume and intensity for local muscular endurance. J Strength Cond Res 2003; 17 (1) 82-87
- 26 Laguardia J, Campos MR, Travassos CM, Najar AL, Anjos LA, Vasconcellos MM. Psychometric evaluation of the SF-36 (v.2) questionnaire in a probability sample of Brazilian households: results of the survey Pesquisa Dimensões Sociais das Desigualdades (PDSD), Brazil, 2008. Health Qual Life Outcomes 2011; 9: 61
- 27 Li X, Lin JF. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Zhonghua Yi Xue Za Zhi 2005; 85 (46) 3266-3271 Chinese
- 28 Copeland JL, Consitt LA, Tremblay MS. Hormonal responses to endurance and resistance exercise in females aged 19-69 years. J Gerontol A Biol Sci Med Sci 2002; 57 (4) B158-B165
- 29 Kogure GS, Miranda-Furtado CL, Silva RC , et al. Resistance exercise impacts lean muscle mass in women with polycystic ovary syndrome. Med Sci Sports Exerc 2016; 48 (4) 589-598
- 30 Miranda-Furtado CL, Ramos FK, Kogure GS , et al. A nonrandomized trial of progressive resistance training intervention in women with polycystic ovary syndrome and its implications in telomere content. Reprod Sci 2016; 23 (5) 644-654
- 31 Miri M, Karimi Jashni H, Alipour F. Effect of exercise intensity on weight changes and sexual hormones (androstenedione and free testosterone) in female rats with estradiol valerate-induced PCOS. J Ovarian Res 2014; 7: 37
- 32 Deschenes MR, Maresh CM, Armstrong LE, Covault J, Kraemer WJ, Crivello JF. Endurance and resistance exercise induce muscle fiber type specific responses in androgen binding capacity. J Steroid Biochem Mol Biol 1994; 50 (3–4) 175-179
- 33 Willoughby DS, Taylor L. Effects of sequential bouts of resistance exercise on androgen receptor expression. Med Sci Sports Exerc 2004; 36 (9) 1499-1506
- 34 Enea C, Boisseau N, Fargeas-Gluck MA, Diaz V, Dugué B. Circulating androgens in women: exercise-induced changes. Sports Med 2011; 41 (1) 1-15
- 35 McTiernan A, Tworoger SS, Rajan KB , et al. Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2004; 13 (7) 1099-1105
- 36 Baker ER, Mathur RS, Kirk RF, Landgrebe SC, Moody LO, Williamson HO. Plasma gonadotropins, prolactin, and steroid hormone concentrations in female runners immediately after a long-distance run. Fertil Steril 1982; 38 (1) 38-41
- 37 Rice S, Patel B, Bano G, Ugwumadu A, Whitehead SA. Aromatase expression in abdominal omental/visceral and subcutaneous fat depots: a comparison of pregnant and obese women. Fertil Steril 2012; 97 (6) 1460-6.e1
- 38 Roessler KK, Birkebaek C, Ravn P, Andersen MS, Glintborg D. Effects of exercise and group counselling on body composition and VO2max in overweight women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 2013; 92 (3) 272-277
- 39 Latorre PA, Santos MA, Heredia-Jiménez JM , et al. Effect of a 24-week physical training programme (in water and on land) on pain, functional capacity, body composition and quality of life in women with fibromyalgia. Clin Exp Rheumatol 2013; 31 (6, Suppl 79) S72-S80
- 40 García-Martínez AM, De Paz JA, Márquez S. Effects of an exercise programme on self-esteem, self-concept and quality of life in women with fibromyalgia: a randomized controlled trial. Rheumatol Int 2012; 32 (7) 1869-1876
- 41 Stener-Victorin E, Holm G, Janson PO, Gustafson D, Waern M. Acupuncture and physical exercise for affective symptoms and health-related quality of life in polycystic ovary syndrome: secondary analysis from a randomized controlled trial. BMC Complement Altern Med 2013; 13: 131
- 42 Myers VH, McVay MA, Brashear MM , et al. Exercise training and quality of life in individuals with type 2 diabetes: a randomized controlled trial. Diabetes Care 2013; 36 (7) 1884-1890
- 43 Courneya KS, Karvinen KH, McNeely ML , et al. Predictors of adherence to supervised and unsupervised exercise in the Alberta Physical Activity and Breast Cancer Prevention Trial. J Phys Act Health 2012; 9 (6) 857-866
- 44 Caruso S, Rugolo S, Agnello C, Romano M, Cianci A. Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate. J Sex Med 2009; 6 (12) 3376-3384
- 45 Urzúa M A, Cortés K, Maita C, Osorio K, Caqueo-Urizar A. [Weight of specific domains on the overall quality of life according to the assessment of participants]. Rev Med Chil 2013; 141 (8) 1010-1018
- 46 Partonen T, Leppämäki S, Hurme J, Lönnqvist J. Randomized trial of physical exercise alone or combined with bright light on mood and health-related quality of life. Psychol Med 1998; 28 (6) 1359-1364
- 47 Li Y, Li Y, Yu Ng EH , et al. Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis. Fertil Steril 2011; 96 (2) 452-458
- 48 Lara LA, Ramos FK, Kogure GS , et al. Impact of physical resistance training on the sexual function of women with polycystic ovary syndrome. J Sex Med 2015; 12 (7) 1584-1590
- 49 Vosnakis C, Georgopoulos NA, Rousso D , et al. Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS). Gynecol Endocrinol 2013; 29 (3) 242-245
- 50 Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil Steril 2004; 82 (2) 421-429